#LCSM Chat Topic 4/2/2020: #COVID19 and #LungCancer

It seems that the world has turned upside down.  At the time I write this, there have been almost 550,00 cases of COVID-19 confirmed in the world and over 85,000 in the US.  Here in New York City there have been over 23,000 cases and 365 deaths as of March 27th (https://coronavirus.jhu.edu/map.html). The pandemic has placed enormous stress on our health care delivery system.  For lung cancer patients, it has affected healthcare providers’ ability to perform tests and radiologic procedures; provide timely diagnosis, staging, and care for early stage patients; and, in… Read More

#LCSM Chat Topic 3/5/2020: Expanding Access to Cancer Clinical Trials

Cancer research is necessary if we are to find more durable treatments for all cancers. While research has come a long way, we still have a long way to go in order to establish quality, durable treatments for many diagnosed with advanced/metastatic disease.  Typically research begins, “at the bench” with cell lines and in organoids. Once an idea has shown some promise, it often moves on to testing in animals. When an idea, test or therapeutic shows significant promise, it must move to clinical trials. Clinical trials, allow diagnostic tests, screening methods,… Read More

#LCSM Chat topic 3-Oct-2019: The Path to Research Advocacy

Please join the #LCSM community and moderator Janet Freeman-Daily (@JFreemanDaily) for our next #LCSM Chat on Thursday, October 3, 2019, at 8 pm Eastern Time (5 pm Pacific) to discuss “The Path to Research Advocacy.” Cancer patients and their loved ones who have the skills, interest, and energy may become patient advocates for their disease. Their activities might include providing support and resources to other patients, acting as liaisons between patients and clinicians, raising awareness and educating others about their disease, and engaging in fundraising activities for advocacy and research. Some patient… Read More